Polypharmacy and Medication Management in Older Adults
Abstract
Polypharmacy in older adults is a global problem that has recently worsened. Approximately 30% of adults aged 65 years and older in developed countries take 5 or more medications. Although prescribed and over-the-counter medications may improve a wide range of health problems, they also may cause or contribute to harm, especially in older adults. Polypharmacy in older adults is associated with worsening of geriatric syndromes and adverse drug events. Given the risks and burdens of polypharmacy and potentially inappropriate medications, nurses must use patient-centered approaches and nonpharmacologic strategies to treat common symptoms and to optimize patient function and quality of life.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Strategies to manage polypharmacy and potentially inappropriate medications in older adults often overlook the role of exercise prescription.
“Strategies to manage polypharmacy and potentially inappropriate medications (PIMs) in older adults often overlook the role of exercise prescription [538,539].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [538]
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609 · see citing works
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M., Ryan, C. A., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,412 · see citing works
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J. M., DeBellis, K. R., Seger, A. C., Cadoret, C. A., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,666 · see citing works
Reducing Inappropriate Polypharmacy
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Couteur, D. G. L., Rigby, D., Gnjidic, D., Mar, C. D., Roughead, E. E., Page, A. T., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,594 · see citing works
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Shehab, N., Lovegrove, M. C., Geller, A. I., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2016) · JAMA · doi:10.1001/jama.2016.16201 · Cited by 664 · see citing works
Optimising drug treatment for elderly people: the prescribing cascade
Rochon, P. A., & Gurwitz, J. H. (1997) · BMJ · doi:10.1136/bmj.315.7115.1096 · Cited by 609 · see citing works
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477 · see citing works
Risk Factors for Adverse Drug Events Among Nursing Home Residents
Field, T. S., Gurwitz, J. H., Avorn, J., McCormick, D., Jain, S., Eckler, M., Benser, M. E., & Bates, D. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1629 · Cited by 412 · see citing works
Cooper, J. A., Cadogan, C. A., Patterson, S. M., Kerse, N. M., Bradley, M. C., Ryan, C. A., & Hughes, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009235 · Cited by 347 · see citing works
Adverse drug events in the outpatient setting: an 11‐year national analysis
Bourgeois, F. T., Shannon, M. W., Valim, C., & Mandl, K. D. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1984 · Cited by 333 · see citing works
High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men
Gnjidic, D., Hilmer, S. N., Blyth, F., Naganathan, V., Cumming, R. G., Handelsman, D. J., McLachlan, A. J., Abernethy, D. R., Banks, E., & Couteur, D. G. L. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.258 · Cited by 303 · see citing works
Cross, A. J., Elliott, R. A., Petrie, K., Kuruvilla, L., & George, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012419.pub2 · Cited by 298 · see citing works
Lu, W., Wen, Y., Chen, L., & Hsiao, F. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.141219 · Cited by 240 · see citing works
Johansson, T., Paier-Abuzahra, M., Keller, S., Mann, E., Faller, B., Sommerauer, C., Höck, J., Löffler, C., Köchling, A., Schuler, J., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12959 · Cited by 235 · see citing works
A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs
Gill, S. S., Mamdani, M., Naglie, G., Streiner, D. L., Bronskill, S. E., Kopp, A., Shulman, K. I., Lee, P. E., & Rochon, P. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.808 · Cited by 234 · see citing works
Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans
Marcum, Z. A., Amuan, M. E., Hanlon, J. T., Aspinall, S. L., Handler, S. M., Ruby, C. M., & Pugh, M. J. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03772.x · Cited by 221 · see citing works
Dwyer, L. L., Han, B., Woodwell, D. A., & Rechtsteiner, E. A. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.01.001 · Cited by 209 · see citing works
Jopp, D. S., Park, M.-K. S., Lehrfeld, J. M., & Paggi, M. E. (2016) · BMC Geriatrics · doi:10.1186/s12877-015-0167-0 · Cited by 201 · see citing works
Methods to reduce prescribing errors in elderly patients with multimorbidity
O’Mahony, D., Gallagher, P., & Lavan, A. H. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s80280 · Cited by 184 · see citing works
Potentially inappropriate medication use in elderly Japanese patients
Akazawa, M., Imai, H., Igarashi, A., & Tsutani, K. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.03.005 · Cited by 175 · see citing works
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
Tsiropoulos, I., Andersen, M. T., & Hallas, J. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1736 · Cited by 138 · see citing works
Palagyi, A., Keay, L. J., Harper, J., Potter, J., & Lindley, R. I. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0181-x · Cited by 130 · see citing works
Minimizing Inappropriate Medications in Older Populations: A 10-step Conceptual Framework
Scott, I. A., Gray, L., Martin, J. H., & Mitchell, C. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.021 · Cited by 127 · see citing works
Nishtala, P. S., & Salahudeen, M. S. (2014) · Gerontology · doi:10.1159/000368191 · Cited by 123 · see citing works
Campins, L., Serra‐Prat, M., Gózalo, I., López, D. O., Palomera, E., Agustí, C., Cabré, M., & on behalf of the REMEI Group (2016) · Family Practice · doi:10.1093/fampra/cmw073 · Cited by 122 · see citing works
Pharmacotherapy Considerations in Elderly Adults
Wooten, J. M. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e31825fed90 · Cited by 105 · see citing works
Nathan, A. (1999) · Family Practice · doi:10.1093/fampra/16.3.278 · Cited by 104 · see citing works
Steinman, M. A., Beizer, J. L., DuBeau, C. E., Laird, R. D., Lundebjerg, N. E., & Mulhausen, P. L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13701 · Cited by 101 · see citing works
Doshi, J. A., Shaffer, T., & Briesacher, B. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53161.x · Cited by 95 · see citing works
Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy
Galazzi, A., Lusignani, M., Chiarelli, M. T., Mannucci, P. M., Franchi, C., Tettamanti, M., Reeve, E., & Nobili, A. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0279-4 · Cited by 90 · see citing works
Saraf, A. A., Petersen, A. W., Simmons, S. F., Schnelle, J. F., Bell, S. P., Kripalani, S. B., Myers, A. P., Mixon, A. S., Long, E. A., Jacobsen, J. M. L., et al. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2614 · Cited by 90 · see citing works
Ellett, L. M. K., Caughey, G. E., Barratt, J. D., Ramsay, E. N., Killer, G. T., Gilbert, A. L., & Roughead, E. E. (2012) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzs015 · Cited by 88 · see citing works
Caughey, G. E., Roughead, E. E., Pratt, N. L., Shakib, S., Vitry, A. I., & Gilbert, A. L. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2009 · Cited by 74 · see citing works
Lucarelli, G. T., Rutigliano, M., Sanguedolce, F., Galleggiante, V., Giglio, A., Cagiano, S., Bufo, P., Maiorano, E., Ribatti, D., Ranieri, E., et al. (2015) · Medicine · doi:10.1097/md.0000000000002117 · Cited by 69 · see citing works
Urfer, M., Elzi, L., Dell‐Kuster, S., & Bassetti, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166359 · Cited by 56 · see citing works
The Ethics of Deprescribing in Older Adults
Reeve, E., Denig, P., Hilmer, S. N., & ter Meulen, R. (2016) · Journal of Bioethical Inquiry · doi:10.1007/s11673-016-9736-y · Cited by 50 · see citing works
Johansson‐Pajala, R., Blomgren, K. J., Bastholm‐Rahmner, P., Fastbom, J., & Martin, L. M. (2016) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2015.1132891 · Cited by 34 · see citing works
Corbi, G., Gambassi, G., Pagano, G., Russomanno, G., Conti, V., Rengo, G., Leosco, D., Bernabei, R., Filippelli, A., & Ferrara, N. (2015) · Medicine · doi:10.1097/md.0000000000000918 · Cited by 33 · see citing works
Oxford Handbook of Clinical Pharmacy
Wiffen, P. J., Mitchell, M., Snelling, M., & Stoner, N. S. (2006) · Oxford University Press eBooks · doi:10.1093/med/9780198567103.001.0001 · Cited by 22 · see citing works
A literature review: Polypharmacy protocol for primary care
Skinner, M. (2015) · Geriatric Nursing · doi:10.1016/j.gerinurse.2015.05.003 · Cited by 21 · see citing works
Cross, A. J., Elliott, R. A., & George, J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012419 · Cited by 21 · see citing works
Polypharmacy: the challenge for nurses
Kaufman, G. (2016) · Nursing Standard · doi:10.7748/ns.30.39.52.s45 · Cited by 19 · see citing works
Monroe, T. B., Carter, M., & Parish, A. L. (2011) · Geriatric Nursing · doi:10.1016/j.gerinurse.2011.07.003 · Cited by 19 · see citing works
Self-citationVejar, M. V., Makic, M. B. F., & Kotthoff‐Burrell, E. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12121 · Cited by 17 · see citing works
Lenander, C., Bondesson, Å., Midlöv, P., & Viberg, N. (2015) · BMC Family Practice · doi:10.1186/s12875-015-0334-6 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273 · see citing works
Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
Kurczewska-Michalak, M., Lewek, P., Jankowska‐Polańska, B., Giardini, A., Granata, N., Maffoni, M., Costa, E. M., Midão, L., & Kardas, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.734045 · Cited by 125 · see citing works
Adverse Drug Reactions (ADR) and Emergencies
Schurig, A. M., Böhme, M., Just, K. S., Scholl, C., Dormann, H., Plank‐Kiegele, B., Seufferlein, T. T. W., Gräff, I., Schwab, M. G., & Stingl, J. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0251 · Cited by 96 · see citing works
Sleep in autism: A biomolecular approach to aetiology and treatment
Ballester, P., Richdale, A. L., Baker, E. K., & Peiró, A. M. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101357 · Cited by 81 · see citing works
Prevalence and factors associated with polypharmacy in the older people: 2006–2014
Carmona‐Torres, J. M., Cobo‐Cuenca, A. I., Recio‐Andrade, B., Laredo‐Aguilera, J. A., Martins, M. M., & Rodríguez‐Borrego, M. A. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14371 · Cited by 78 · see citing works
Ye, L., Yang‐Huang, J., Franse, C. B., Rukavina, T., Vasiljev, V., Mattace-Raso, F. U. S., Verma, A., Borrás, T. A., Rentoumis, A., & Raat, H. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03536-z · Cited by 76 · see citing works
“sociodemographic, lifestyle and nutrition, as well as health and health care use) is associated with polypharmacy; also, relatively few studies assess the factors associated with the high risk of medication-related problems [18, 19].”
BackgroundImproved prediction of drug-drug interactions using ensemble deep neural networks
Vo, T. H., Nguyen, N. T. K., & Le, N. Q. K. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100149 · Cited by 66 · see citing works
Pharmacological Interactions in the Elderly
Błeszyńska-Marunowska, E., Wierucki, Ł., Zdrojewski, T. R., & Renke, M. (2020) · Medicina · doi:10.3390/medicina56070320 · Cited by 63 · see citing works
“It is estimated that in developed countries about 30–40% of people over 65 years old take 5 or more drugs, while 12% of patients in this age group use 10 or more different medicines [2].”
BackgroundMethodInfluentialSafety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
Klietz, M., Greten, S., Wegner, F., & Höglinger, G. U. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00654-z · Cited by 62 · see citing works
Bonanno, E. G., Figueiredo, T., Mimoso, I., Morgado, M. I., Carrilho, J., Midão, L., & Costa, E. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041330 · Cited by 54 · see citing works
“This condition is particularly pronounced in certain subgroups: around 45% of individuals aged over 65 are affected, compared to younger adults, with prevalence reaching 52% among hospitalized patients [33].”
Krustev, T., Milushewa, P., & Tachkov, K. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.743138 · Cited by 48 · see citing works
Midão, L., Brochado, P., Almada, M., Duarte, M. G., Paúl, C., & Costa, E. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073580 · Cited by 45 · see citing works
“Life expectancy and care goals need to be taken into account when reviewing a patient’s list with each medication’s benefits and problems being weighed [30].”
BackgroundMedication self-management: Considerations and decisions by older people living at home
Dijkstra, N. E., Sino, C. G. M., Schuurmans, M. J., Schoonhoven, L., & Heerdink, E. R. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.09.004 · Cited by 44 · see citing works
Zinc deficiency as possible link between immunosenescence and age-related diseases
Schulz, M., & Rink, L. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00511-1 · Cited by 42 · see citing works
“Thiazide diu-retics increase urinary excretion of zinc [36–39].”
Developing a competence framework for nurses in pharmaceutical care: A Delphi study
Dijkstra, N. E., Baetselier, E. D., Dilles, T., Rompaey, B. V., Batalha, L., Filov, I., Grøndahl, V. A., Heczková, J., Helgesen, A. K., Jordan, S. E., et al. (2021) · Nurse Education Today · doi:10.1016/j.nedt.2021.104926 · Cited by 42 · see citing works
“…delivering, administering medication, providing patient education, and monitoring and evaluating the effectiveness and efficacy of the medicine, sometimes with distinct and sometimes with overlapping roles (Dilles et al., 2010; Kim and Parish, 2017; Lee et al., 2015; Stegemann et al., 2010).”
BackgroundLertkovit, S., Siriussawakul, A., Suraarunsumrit, P., Lertpipopmetha, W., Manomaiwong, N., Wivatdechakul, W., & Srinonprasert, V. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.811954 · Cited by 37 · see citing works
Gomides, A. P. M., de Albuquerque, C. P., Vargas‐Santos, A. B., Amorim, R. B. C., Bértolo, M. B., Louzada‐Júnior, P., Santos, I. A., Giorgi, R. D. N., Sacilotto, N., Radominski, S., et al. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019869158 · Cited by 37 · see citing works
“The occurrence and consequences of polypharmacy have been studied extensively in the elderly and in patients with other chronic diseases, such as heart disease or cancer.(13-18) In rheumatology, to our knowledge, there is a shortage of studies on polypharmacy and its consequences.”
BackgroundResultCognitive performance in older adults across Europe based on the SHARE database
Barbosa, R., Midão, L., Almada, M., & Costa, E. M. (2020) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2020.1799927 · Cited by 36 · see citing works
“Inappropriate polypharmacy increases the risk of unwanted outcomes, such as more severe adverse effects and drug–drug interactions, especially in older adults (Kim & Parish, 2017; Komiya et al., 2018; Maher et al., 2014).”
BackgroundGao, S., Sun, S., Sun, T., Lu, T., Ma, Y., Che, H., Liu, M., Xue, W., He, K., Wang, Y., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18006-x · Cited by 35 · see citing works
“While there is no consensus on the medication threshold, polypharmacy is often commonly defined as concomitant use of 5 or more medications [15, 16].”
BackgroundVatcharavongvan, P., & Puttawanchai, V. (2019) · Pharmacy Practice · doi:10.18549/pharmpract.2019.3.1494 · Cited by 34 · see citing works
“Polypharmacy, the concurrent use of multiple medications in elderly patients is common worldwide.(1) Polypharmacy increases the risk of negative health outcomes, including adverse drug events (ADEs), drug-disease or drugsyndrome interactions, and potentially inappropriate medications (PIMs).”
BackgroundRebalancing the unbalanced aged immune system – A special focus on zinc
Baarz, B. R., & Rink, L. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101541 · Cited by 35 · see citing works
Prevalence and Risk of Polypharmacy among Community-Dwelling, Elderly Kuwaiti Patients
Badawy, N. A., Labeeb, S. A., Alsamdan, M. F., & Alazemi, B. F. (2019) · Medical Principles and Practice · doi:10.1159/000503298 · Cited by 33 · see citing works
Wakai, E., Ikemura, K., Kato, C., & Okuda, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252944 · Cited by 33 · see citing works
“Polypharmacy, defined as inappropriate prescriptions that are more than necessary, is known to be a global issue and has been one of the important causes of decreased medication adherence [17].”
BackgroundRadha Krishnan, R. P., Hung, E. H., Ashford, M., Edillo, C. E., Gardner, C., Hatrick, H. B., Kim, B., Lai, A. W. Y., Li, X., Zhao, Y. X., et al. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16275 · Cited by 29 · see citing works
Healthy ageing in older adults with cardiovascular disease
Schmanske, N., Ngo, J. M., Kalra, K., Nanna, M. G., & Damluji, A. A. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf231 · Cited by 28 · see citing works
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence
Butranova, O. I., Ushkalova, E. A., Zyryanov, S. K., Станиславович, Ч. М., & Александровна, Б. Е. (2023) · Biomedicines · doi:10.3390/biomedicines11061633 · Cited by 30 · see citing works
Ghasemi, H., Darvishi, N., Salari, N., Far, A. H., Akbari, H., & Mohammadi, M. (2022) · Tropical Medicine and Health · doi:10.1186/s41182-022-00456-x · Cited by 27 · see citing works
“Polypharmacy in the elderly is a global problem that has recently worsened [13].”
BackgroundPolypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.
Thelen, J., Zvonarev, V., Lam, S., Burkhardt, C. D., LYNCH, S. G., & Bruce, J. M. (2021) · PubMed Central · Cited by 26 · see citing works
Lampe, D., Grosser, J., Gensorowsky, D., Witte, J., Muth, C., van den Akker, M., Dinh, T. S., & Greiner, W. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01022-8 · Cited by 27 · see citing works
“Suboptimal care transitions and a lack of collaboration between health care providers (e.g., physicians) have been identified as major problems impeding optimal medication management processes and patient safety [20–23].”
Izquierdo, M., Ramírez‐Vélez, R., & Singh, M. F. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100763 · Cited by 29 · see citing works
Clinical outcomes of geriatric patients with COVID-19: review of one-year data
Avcı, G. U., Kanat, B. B., Suzan, V., Can, G., Korkmazer, B., Karaali, R., Tabak, F., Börekçi, Ş., Aygün, G., Yavuzer, H., et al. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-02047-y · Cited by 24 · see citing works
“The use of five or more drugs on admission was considered polypharmacy [7, 8].”
BackgroundNgcobo, N. N. (2025) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70283 · Cited by 22 · see citing works
“The World Health Organization (WHO) acknowledges this as a significant issue, though international data comparison remains challenging due to varying healthcare systems [9, 109].”
Li, M., Wei, N., Shi, H., Jing, X.-J., Kan, X.-H., Gao, H.-Q., & Xiao, Y.-L. (2023) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2023.07.002 · Cited by 22 · see citing works
Association of polypharmacy with occurrence of loneliness and social isolation among older adults
Svensson, M., Ekström, H., Elmståhl, S., & Rosso, A. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.105158 · Cited by 22 · see citing works
Polifarmácia, medicamentos potencialmente inapropriados e a vulnerabilidade de pessoas idosas
de Andrade, R. C., dos Santos, M. M., Ribeiro, E. E., dos Santos, J. D. O., Campos, H. L. M., & de Leon, E. B. (2024) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562024027.230191.pt · Cited by 17 · see citing works
“Diante disso se faz necessário analisar prejuízos e benefícios das prescrições de medicamentos e a repercussão que os MPI têm sobre a saúde da pessoa idosa 26 .”
BackgroundZhang, H., Wong, E. L., Yeoh, E., & Ma, B. H. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02024-0 · Cited by 17 · see citing works
Dose‐dependent association between xerostomia and number of medications among older adults
Storbeck, T., Qian, F., Marek, C. L., Caplan, D. J., & Marchini, L. (2021) · Special Care in Dentistry · doi:10.1111/scd.12662 · Cited by 17 · see citing works
Kefale, B., Engidaw, M. T., Tesfa, D., Yazie, T. S., Molla, M., & Yismaw, M. B. (2022) · SAGE Open Medicine · doi:10.1177/20503121221131691 · Cited by 17 · see citing works
The Relationship Between a Mediterranean Diet and Frailty in Older Adults: NHANES 2007–2017
Gross, D. C., Dahringer, J. C., Bramblett, P. N., Sun, C., Spangler, H., Lynch, D. H., & Batsis, J. A. (2025) · Nutrients · doi:10.3390/nu17020326 · Cited by 16 · see citing works
“Self-reported polypharmacy, taking five or more medications, was included because of its relationship with an increased risk of geriatric syndromes such as frailty and falls [23].”
Lee, J. W., Li, M., Boyd, C. M., Green, A. R., & Szanton, S. L. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.11.005 · Cited by 16 · see citing works
Disclosure of Complementary and Alternative Medicine Use Among Older Adults: A Cross-Sectional Study
Golden, J., Kenyon‐Pesce, L., Robison, J. T., Grady, J. J., & Guerrera, M. P. (2023) · Gerontology and Geriatric Medicine · doi:10.1177/23337214231179839 · Cited by 17 · see citing works
“This growing trend of CAM use may be of particular importance in older patients given the prevalence of chronic illness and polypharmacy in this population (Kim & Parish, 2017; National Council on Aging, 2018).”
BackgroundCui, Y., Zhu, C., Lian, Z., Han, X., Xiang, Q., Liu, Z., & Zhou, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03492-9 · Cited by 15 · see citing works
Cheng, C., Yu, H., & Wang, Q. (2023) · Healthcare · doi:10.3390/healthcare11030334 · Cited by 15 · see citing works
“Nurses play an important role in helping to identify people with polypharmacy and facilitating risk reduction [9].”
BackgroundBauman, Z. M., Yanala, U., Waibel, B. H., Malhotra, G. K., Cemaj, S., Evans, C. H., & Schlitzkus, L. L. (2021) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-020-01568-x · Cited by 14 · see citing works
Lifestyle or pharmacotherapy in cardio-metabolic disease prevention
Seidu, B. S., Osman, H., & Seidu, S. (2023) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447231177175 · Cited by 14 · see citing works
Wang, X., Huang, L., Wang, D., Liu, L., & Guo, P. (2025) · IEEE Access · doi:10.1109/access.2025.3596694 · Cited by 15 · see citing works
Ierodiakonou, D., Theodorou, E., Sifaki-Pistolla, D. I., Bouloukaki, I., Antonopoulou, M., Poulorinakis, I., Tsakountakis, N., Voltiraki, F., Chliveros, K., & Tsiligianni, I. (2021) · The Clinical Respiratory Journal · doi:10.1111/crj.13434 · Cited by 13 · see citing works
Bortolussi‐Courval, É., Podymow, T., Battistella, M., Trinh, E., Mavrakanas, T. A., McCarthy, L. M., Moryousef, J., Hanula, R., Huon, J., Suri, R. S., et al. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100810 · Cited by 13 · see citing works
Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?
Saeed, Z. I., Ostrominski, J. W., & Aroda, V. R. (2024) · Diabetes Care · doi:10.2337/dci24-0035 · Cited by 14 · see citing works
Christopher, C. M., Bhuvan, K. C., Blebil, A. Q., Alex, D., Ibrahim, M. I. M., Ismail, N., & Alrasheedy, A. A. (2021) · Healthcare · doi:10.3390/healthcare9111577 · Cited by 13 · see citing works
Castro‐Rodríguez, A., Machado‐Duque, M. E., Gaviria‐Mendoza, A., Medina-Morales, D. A., Tatiana, Á.-V., & Machado‐Alba, J. E. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13278 · Cited by 13 · see citing works
da Silva, A. M., do Carmo, A. S., Alves, V. P., & de Carvalho, L. S. F. (2023) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2022-0592 · Cited by 20 · see citing works
“hypnotics, sedatives, anxiolytics, antipsychotics, and anti-ulcer agents) (23,38-39).”
BackgroundConsistency between anticholinergic burden scales in the elderly with fractures
Valladales‐Restrepo, L. F., Lengua, M. D., Castro-Osorio, E. E., & Machado‐Alba, J. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228532 · Cited by 12 · see citing works
“Polypharmacy is associated with the development and worsening of geriatric syndromes, including falls [2] and is involved in the increase in adverse drug reactions (ADR), hospitalizations, complexity of care, morbidity and mortality [3].”
BackgroundCombating Polypharmacy Through Deprescribing Potentially Inappropriate Medications
Chou, J., Tong, M., & Brandt, N. (2019) · Journal of Gerontological Nursing · doi:10.3928/00989134-20190102-01 · Cited by 12 · see citing works
Polypharmacy and Related Factors in Geriatric Outpatients
Küçükdağlı, P. (2019) · European Journal of Geriatrics and Gerontology · doi:10.4274/ejgg.galenos.2019.144 · Cited by 12 · see citing works
“World Health Organization defined adverse drug events as ‘‘Unintended and undesired effects of a medication at a normal dose’’ and classified into five categories as adverse drug reaction, medication error, therapeutic failure, drug withdrawal and overdose (7-9).”
Drug-induced olfactory and gustatory dysfunction: Analysis of FDA adverse events reporting system
Debbaneh, P. M., McKinnon, L., Haidari, M., & Liang, J. Z. (2023) · Auris Nasus Larynx · doi:10.1016/j.anl.2022.12.012 · Cited by 11 · see citing works
Recent Updates on Risk and Management Plans Associated with Polypharmacy in Older Population
Alshanberi, A. M. (2022) · Geriatrics · doi:10.3390/geriatrics7050097 · Cited by 12 · see citing works
Dificuldades no uso de medicamentos por idosos acompanhados em uma coorte do Sul do Brasil
Guttier, M. C., Silveira, M. P. T., Tavares, N. U. L., Krause, M. C., Bielemann, R. M., González, M. C., Tomasi, E., Demarco, F. F., & Bertoldi, A. D. (2023) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720230020.2 · Cited by 11 · see citing works
“Nenhum 147 (12,8) 30,7 (26,6–38,8) 5,5 (3,2–9,2) 3,0 (1,6–5,4)”
Hung, C.-D., Yang, C., Lee, C., Hu, S. C., Chen, S., Hung, C., Chuang, H., Chen, C., & Kuo, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194413 · Cited by 10 · see citing works
Current Landscape and Future Directions of Deprescribing and Polypharmacy Practices in Jordan
Barakat, M. M., Nassar, R. I., Gharaibeh, L. F., Thiab, S. H., & Nashwan, A. J. (2024) · Medical Principles and Practice · doi:10.1159/000541009 · Cited by 10 · see citing works
Understanding constipation as a geriatric syndrome
Cheever, C. R., Shams, R. B., Willingham, K. R., Sim, H., Cook, L. M., Ahmidouch, M. Y., Scholand, K. E., & Wilson, L. A. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.12.012 · Cited by 10 · see citing works
Mena, S., Moullin, J. C., Schneider, M. P., & Niquille, A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04335-w · Cited by 10 · see citing works
“Both are a concern due to their association with adverse effects such as falls or cognitive impairment [3– 6].”
BackgroundAbraham, A. B., Alzahrani, A. Y. A., & Thomas, R. (2023) · Zeitschrift für Physikalische Chemie · doi:10.1515/zpch-2023-0390 · Cited by 9 · see citing works
Polypharmacy, potentially inappropriate medications, and the vulnerability of older adults
de Andrade, R. C., dos Santos, M. M., Ribeiro, E. E., dos Santos, J. D. O., Campos, H. L. M., & de Leon, E. B. (2024) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562024027.230191.en · Cited by 9 · see citing works
“Therefore, it is necessary to analyze the harms and benefits of medication prescriptions and the impact that potentially inappropriate medications (PIM) have on the health of older adults 26 .”
BackgroundGlans, M., Kempen, T. G. H., Jakobsson, U., Ekstam, A. K., Bondesson, Å., & Midlöv, P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070559 · Cited by 9 · see citing works
“Emergency admission, as opposed to planned admission, has been indicated as a risk factor for 30-day readmission in several studies, including ours, 10 22 and the factor is included in both the HOSPITAL Score 27 and the LACE Index.”
Brandt, N., Simoni, J. M., & Sharma, K. (2018) · Public Policy & Aging Report · doi:10.1093/ppar/pry041 · Cited by 9 · see citing works
Oriental herbal medicine for insomnia in the elderly with hypertension
Kwon, C., Lee, B., Chung, S.-Y., Kim, J. W., & Kim, S.-H. (2018) · Medicine · doi:10.1097/md.0000000000012200 · Cited by 9 · see citing works
“More importantly, the issue of polypharmacy in the elderly population was highlighted recently.([23]) Polypharmacy is described as taking ≥5 medications daily.”
BackgroundSelf-citationTamene, F. B., Zeleke, T. K., Desalew, A. F., Tarekegn, G. Y., Sendekie, A. K., Tafere, S. M., Kiflu, M., Moges, T. A., Dagnew, F. N., & Wondm, S. A. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02011-1 · Cited by 8 · see citing works
“The use of five or more medications is the most prevalent definition of poly-pharmacy, which has historically been linked to harmful consequences despite these differences and it’s estimated prevalence ranges from 57 to 84% [8, 9].”
Vitamin D and depression in older adults: lessons learned from observational and clinical studies
Ceolin, G., Antunes, L. D. C., Moretti, M., Rieger, D. K., & Moreira, J. D. (2022) · Nutrition Research Reviews · doi:10.1017/s0954422422000026 · Cited by 8 · see citing works
Research status and hotspots of medication safety in older adults: A bibliometric analysis
Xie, C., Gu, Y., Wang, Y., Ni, F., & Li, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.967227 · Cited by 8 · see citing works
“Prevention of damage due to medication mismanagement is a growing challenge in clinical practice, especially for older adults who are subject to chronic care and the prescription of moremedications (6, 7).”
BackgroundZhang, B., Wang, J., Liu, N., Liu, W., Xi, R., & Wang, P. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03606-x · Cited by 8 · see citing works
“Therefore, medical staff should pay attention to the possibility that elderly patients may experience more diverse reactions when taking multiple medications [37].”
BackgroundTakeda, F., Oda, M., Terasaki, M., Kubota, A., Asada, K., Ichimura, Y., Kojima, H., & Saitoh, H. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100411 · Cited by 8 · see citing works
Zhang, H., Wong, E. L., Wong, S. Y. S., Chau, P. Y., Yip, B. H. K., Chung, R. Y., Lee, E. K. P., Lai, F. T. T., & Yeoh, E. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051527 · Cited by 8 · see citing works
Wongtangman, T., Thatphet, P., Shokoohi, H., McFadden, K., Ma, I. W. Y., Saud, A. A. A., Vivian, R., Hines, R., Gullikson, J., Morone, C. C., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041251 · Cited by 8 · see citing works
“Although the term of polypharmacy does not have clear-cut definition [37] following multiple studies, we defined polypharmacy as using 5 or more medications [38,39].”
Air pollution exposure is associated with rhinitis in older US adults via specific immune mechanisms
Scussiatto, H. O., Wroblewski, K., Pagel, K. L., Schumm, L. P., McClintock, M. K., Ramanathan, M., Suh, H. H., & Pinto, J. M. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23225 · Cited by 8 · see citing works
“42,43 Our outcomes were robust to the addition of age, sex, race/ethnicity, education, cigarette smoking, and BMI.”
BackgroundInterventions to optimize prescribing for older people in care homes
Neville, C. C. (2019) · International Journal of Nursing Practice · doi:10.1111/ijn.12763 · Cited by 7 · see citing works
Jairoun, A. A., Al‐Hemyari, S. S., Shahwan, M. J., El‐Dahiyat, F., Jairoun, M., Godman, B., Kurdi, A. B., & Zyoud, S. H. (2022) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmac044 · Cited by 7 · see citing works
Potentially Inappropriate Medication: A Pilot Study in Institutionalized Older Adults
Andrade, A., Nascimento, T., Cabrita, C., Leitão, H. S., & Pinto, E. A. M. (2024) · Healthcare · doi:10.3390/healthcare12131275 · Cited by 7 · see citing works
“Thus, individual needs, pharmacokinetic and pharmacodynamic changes, polymedication, and multimorbidity are risk factors that should be considered in pharmacotherapeutic analyses in this population [19].”
BackgroundOhta, R., Yoshioka, K., & Sano, C. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02540-z · Cited by 7 · see citing works
“Admitted older patients tend to have multimorbid conditions requiring polypharmacy, and they can develop various medical problems [14]; therefore, organ-specific specialists may be unable to effectively manage such patients [2].”
BackgroundCatrini, E., Ferrario, L. B., Mazzone, A., Varalli, L., Gatti, F., Cannavacciuolo, L., Ponsiglione, C., & Foglia, E. (2022) · Health Science Reports · doi:10.1002/hsr2.647 · Cited by 6 · see citing works
Koubaity, M., Lechon, A.-S., Amighi, K., Nuffelen, M. V., Moreau, M., Meert, A., & Vriese, C. D. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05916-w · Cited by 7 · see citing works
“Polypharmacywas the last risk factor leading to a readmission [12, 13].”
BackgroundTakeda, F., Oda, M., Terasaki, M., Ichimura, Y., Kojima, H., & Saitoh, H. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115570 · Cited by 7 · see citing works
Lynnerup, C., Rossing, C., Sodemann, M., Ryg, J., Pottegård, A., & Nielsen, D. S. (2022) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2022.100128 · Cited by 6 · see citing works
Maltais, A., Simard, M., Vedel, I., & Sirois, C. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000513 · Cited by 6 · see citing works
“(3) A claim for a medication to treat MNCD in the pharmaceutical services database.”
BackgroundPolimedicação em Idosos Submetidos a Tratamento Oncológico
Alves, B. L. P., da Silva, V. G. N., Caetano, I. B. M. O. S., Livinalli, A., & Cruz, M. L. (2020) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2019v65n4.379 · Cited by 6 · see citing works
Over-The-Counter Remedies in Older Adults
Safari, D., DeMarco, E. C., Scanlon, L., & Grossberg, G. T. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.005 · Cited by 6 · see citing works
Hirata, I., Hanaoka, S., Rokutanda, R., Funakoshi, R., & Hayashi, H. (2023) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2023.11135 · Cited by 6 · see citing works
“The number of drugs used was classified into two categories based on a previous report on polypharmacy (13).”
BackgroundKovačević, T., Davidović, M. S., Barišić, V., Fazlić, E., Miljković, S., Djajić, V., Miljković, B., & Kovačević, P. (2024) · Pharmacy · doi:10.3390/pharmacy12030084 · Cited by 6 · see citing works
“In HICs, people aged 65 to 74 years reported three times more adverse drug reactions, per million inhabitants per year, compared to younger people aged 5 to 19 years [4].”
BackgroundInfluentialDiggins, K. C. (2019) · The Nurse Practitioner · doi:10.1097/01.npr.0000554677.33988.af · Cited by 6 · see citing works
Lai, C. K. Y., Holyoke, P., Plourde, K. V., Décary, S., & Légaré, F. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039102 · Cited by 6 · see citing works
Drug–drug interactions: A descriptive analysis of FDA adverse event reporting system
Alahmari, A. K., Fatani, S., & Ahmed, N. J. (2025) · Medicine · doi:10.1097/md.0000000000044606 · Cited by 5 · see citing works
Lagerin, A., Törnkvist, L., Fastbom, J., & Lundh, L. (2021) · Primary Health Care Research & Development · doi:10.1017/s1463423621000530 · Cited by 5 · see citing works
“, 2018), which increases the risk of ADR and drug– drug interactions and has a negative impact on medication adherence (Hughes, 2004; Lagerin et al., 2014; Kim, 2017).”
Backgroundda Silva, A. M., do Carmo, A. S., Alves, V. P., & de Carvalho, L. S. F. (2023) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2022-0592pt · Cited by 5 · see citing works
Wu, W., Tang, Q., Wang, C., Cao, Y., Liu, Z., Li, X., Chen, G., & Lü, J. (2022) · BioScience Trends · doi:10.5582/bst.2022.01021 · Cited by 5 · see citing works
“Polypharmacy: at present, there is no recognized definition of polypharmacy in the international academic community, and there are still differences in the number and degree of multiple drug uses (16-17).”
BackgroundHerbal medicine for insomnia in elderly with hypertension: A systematic review and meta-analysis
Kwon, C., Lee, B., Chung, S.-Y., Kim, J. W., & Kim, S.-H. (2019) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2019.100961 · Cited by 5 · see citing works
Self-citationGraeff, V., Wehler, M., Dormann, H., Stingl, J., Just, K. S., & Eisert, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14175921 · Cited by 4 · see citing works
“In addition to PIMs, the increase in the number of drug therapies with increasing age due to comorbidities has been scientifically proven [39–41], and polypharmacy is a significant risk factor for the occurrence of ADRs [42].”
Navarrete-Anaya, Y. V., Delgado‐Enciso, I., Hernández‐Fuentes, G. A., Diaz‐Martinez, J., Delgado‐Enciso, O. G., Sánchez-Arizmendi, A., Figueroa-Gutiérrez, A., Aguilar-Cota, J., Venegas-Ramírez, J., Calvo-Soto, P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196951 · Cited by 5 · see citing works
“Clinically, these findings support the importance of evaluating sleep quality and medication use in older men with ED [42,43].”
Factors related to polypharmacy in elderly people assisted by a Family Health Unit in Manhuaçu – MG
da Silva, G. H. D. M., Silva, M. S. A., Oliveira, G. P. L., Pampolim, G., & Sogame, L. C. M. (2024) · Clinics Biopsychosocial · doi:10.54727/cbps.v1i1.2 · Cited by 4 · see citing works
Dietary supplement use is common in older adult drivers: an analysis from the AAA LongROAD study
Moran, R. J., Baird, S., DiGuiseppi, C. G., Eby, D. W., Hacker, S., Isom, C. A., Jones, V., Lee, K. C., Li, G., Molnar, L. J., et al. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04623-x · Cited by 4 · see citing works
Kijpaisalratana, N., Ariss, A.-B., Balk, A., Mitragotri, S., Samadian, K. D., Hahn, B. J., Coleska, A., Baugh, J. J., Hassan, A., Lee, J., et al. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.04.045 · Cited by 4 · see citing works
- Authors
- Kim, J., & Parish, A. L.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Kim, Jennifer
- ORCID
- Parish, Abby Luck
- Venue
- Nursing Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 52
- Issue
- 3
- Pages
- 457-468
- ISSN
- 0029-6465 (ISSN-L)
- OpenAlex
- W2739733993
- Cited by
- 245
- References
- 45
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 47 · 2023: 44 · 2022: 34 · 2021: 38 · 2020: 15 · 2019: 18 · 2018: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nursing Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Keywords
- polypharmacy, older adults, medication management, potentially inappropriate medications, adverse drug reactions, geriatric syndromes, patient-centered care, non-pharmacological treatment, quality of life, nursing care
- MeSH terms
- Aged, Humans, Polypharmacy, Nurse's Role, Medication Therapy Management, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review